Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

5%

Beneficial ownership of this reported class.

Shares

7,366,818 shares

Shares beneficially owned as disclosed.

Event date

25 Nov 2025

Date tied to the ownership event or amendment.

Accepted by SEC

28 Nov 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
CNTA
Shares outstanding
147,336,360 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
28 Nov 2025, 17:11:59 UTC
Event date
25 Nov 2025
Prior SEC filing
17 Nov 2025
Source filing
View source filing

Key filing fact

General Atlantic Cooperatief U.A. disclosed 5% ownership in Centessa Pharmaceuticals plc Ordinary shares, par value 0.002 GBP per share (CNTA) on 25 Nov 2025.

Key facts

  • General Atlantic Cooperatief U.A. filed SCHEDULE 13D/A for Centessa Pharmaceuticals plc Ordinary shares, par value 0.002 GBP per share (CNTA).
  • Disclosed ownership: 5%.
  • Date of event: 25 Nov 2025.

Change

  • Previous schedule filing date: 17 Nov 2025.
  • Current filing was accepted on 28 Nov 2025, 17:11.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (10)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
General Atlantic Cooperatief U.A. 5% 7,366,818 0 7,366,818 /s/ I.M. van der Hoorn I.M. van der Hoorn, Director A 0001859266
General Atlantic UM B.V. 5% 7,366,818 0 7,366,818 /s/ I.M. van der Hoorn I.M. van der Hoorn, Director A
General Atlantic Partners (Bermuda) IV, L.P. 5% 7,366,818 0 7,366,818 /s/ Michael Gosk Michael Gosk, Managing Director of GAP (BERMUDA) LIMITED, the general partner of GENERAL ATLANTIC GENPAR (BERMUDA), L.P., its general partner
General Atlantic Partners (Bermuda) EU, L.P. 5% 7,366,818 0 7,366,818 /s/ Michael Gosk Michael Gosk, Managing Director of GAP (BERMUDA) LIMITED, the general partner of GENERAL ATLANTIC GENPAR (BERMUDA), L.P., its general partner
General Atlantic Partners (Lux) SCSp 5% 7,366,818 0 7,366,818 /s/ Ingrid van der Hoorn Ingrid van der Hoorn, Manager A of GENERAL ATLANTIC (LUX) S.A R.L., the general partner of GENERAL ATLANTIC GENPAR (LUX) SCSP, its general partner
General Atlantic GenPar (Lux) SCSp 5% 7,366,818 0 7,366,818 /s/ Ingrid van der Hoorn Ingrid van der Hoorn, Manager A of GENERAL ATLANTIC (LUX) S.A R.L.
General Atlantic (Lux) S.a r.l. 5% 7,366,818 0 7,366,818 /s/ Ingrid van der Hoorn Ingrid van der Hoorn, Manager A
General Atlantic GenPar (Bermuda), L.P. 5% 7,366,818 0 7,366,818 /s/ Michael Gosk Michael Gosk, Managing Director of GAP (BERMUDA) LIMITED, its general partner
GAP (Bermuda) Limited 5% 7,366,818 0 7,366,818 /s/ Michael Gosk Michael Gosk, Managing Director
General Atlantic Cooperatief, L.P. 5% 7,366,818 0 7,366,818 /s/ Michael Gosk Michael Gosk, Managing Director of GAP (BERMUDA) LIMITED, its general partner
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .